AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Ampio Pharmaceuticals, Inc.
  3. Financials
  4. Net income

Ampio Pharmaceuticals, Inc.【AMPE】

Market cap
$317.9K
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2023-9-47.16%
Dec 31, 2022-16-4.32%
Dec 31, 2021-17+7.43%
Dec 31, 2020-16+16.61%
Dec 31, 2019-14-140.10%
Dec 31, 201834-165.49%
Dec 31, 2017-52+170.78%
Dec 31, 2016-19-40.13%
Dec 31, 2015-32-16.04%
Dec 31, 2014-38+58.80%
Dec 31, 2013-24+107.09%
Dec 31, 2012-12-36.85%
Dec 31, 2011-18

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)